Erweiterte Suche

Derzeit bekleidet Sren Tulstrup die Position des President & Chief Executive Officer bei Hansa Biopharma AB. Herr Tulstrup ist außerdem Senior Vice President für Shire Human Genetic Therapies, Inc. Zuvor war Herr Tulstrup Chief Executive Officer für Vifor Pharma AG und Chief Executive Officer der Vifor Pharma Management AG (eine Tochtergesellschaft der Vifor Pharma AG), Vice President-Global Human Health bei Merck & Co. und Managing Director-Denmark bei Merck Sharp & Dohme Ltd. (eine Tochtergesellschaft von Merck & Co., Inc.), stellvertretender Regional Manager bei der Novartis AG und Principal bei Sandoz, Inc. (eine Tochtergesellschaft der Novartis AG), Principal bei Abbott Laboratories, President & Chief Executive Officer für Roche Innovation Center Copenhagen An und Senior Vice President für Shire Pharmaceuticals, Inc. Er erwarb einen Abschluss an der Copenhagen Business School und einen Abschluss an der Northwestern University.

Eric J.
Sorenson is currently the Director at Amazement Square Children's Museum and the Principal at Woods Rogers Plc.
He completed his undergraduate degree at Washington & Lee University School of Law.

Prior to joining Leeds Equity in 1998, Mr. Sorensen spent three years within the mergers and acquisitions and corporate finance departments at Bear Stearns.
Mr. Sorensen was involved in our recent acquisition of Education Management Corporation and our sale of Ross University to DeVry, Inc. He also served on the board of Ross University.
Mr. Sorensen graduated summa cum laude from Bowdoin College with a B.A.
degree in Economics and French.

Perry Sorenson served as the Chief Operating Officer at Outrigger Hotels & Resorts and Outrigger Enterprises, Inc.